Update information
Minor changes since publication
June 2026: We added links to relevant technology appraisal guidance in the sections on treating follicular lymphoma, marginal zone lymphoma, mantle cell lymphoma, diffuse large B-cell lymphoma, relapsed or refractory high-grade B-cell lymphoma, relapsed or refractory primary mediastinal large B-cell lymphoma and Waldenstrom's macroglobulinaemia. We also simplified the guideline by removing recommendations on general principles of care that are covered in other NICE guidelines.
October 2021: We added links to EuroTEST's HIV indicator conditions and NICE's guideline on HIV testing to section 1.1 on diagnosis. See the surveillance report on HIV indicator conditions for more information.
ISBN: 978‑1‑4731‑1963‑5